# Siemens Healthineers

> Siemens Healthineers is a German medical technology company that supplies hospitals, laboratories, clinics, public health systems and researchers with imaging systems, in-vitro diagnostics, precision cancer and minimally invasive therapies, software, training and long-term operational services. Its scale comes from combining capital equipment such as CT and MRI scanners with recurring service, spare-parts and reagent revenue, while its newest strategy organizes the portfolio around Imaging, Precision Therapy and Diagnostics.

- **Founded:** 2015
- **Headquarters:** Forchheim, Germany
- **Team size:** Approximately 74,300 employees as of June 30, 2026; about 74,000 at the end of fiscal 2025.
- **Products:** Medical imaging, NAEOTOM Alpha class, Atellica diagnostics, Varian cancer care, Precision Therapy
- **Notable:** The Siemens medical-technology lineage produced an industrially manufactured medical X-ray device in 1896, one year after the discovery of X-rays., Siemens Healthineers listed on the Frankfurt Stock Exchange on March 16, 2018 and entered Germany's DAX index in September 2021., Completed the combination with Varian Medical Systems in April 2021, adding a broad radiation-oncology and cancer-care portfolio.

## Products & services

- **Medical imaging** — MRI, computed tomography, X-ray, molecular imaging and ultrasound systems, plus shared software for image reading and structured reporting.
- **NAEOTOM Alpha class** — Photon-counting CT systems that directly convert X-ray photons into electrical signals to improve image information and support lower-dose or more precise exams.
- **Atellica diagnostics** — Laboratory and point-of-care analyzers, automation, informatics and assay menus spanning immunochemistry, hematology, hemostasis, urinalysis, diabetes and blood gas testing.
- **Varian cancer care** — Image-guided radiotherapy, treatment planning, oncology software, patient engagement and professional services for cancer centers.
- **Precision Therapy** — Angiography, mobile C-arms, ultrasound, image-guided minimally invasive systems, endovascular robotics development and AI-powered clinical applications.
- **Digital and AI solutions** — Clinical applications, image reconstruction, workflow automation, fleet management, healthcare IT and software intended to make scarce clinical capacity more productive.
- **Value Partnerships** — Multi-year, performance-oriented relationships covering technology modernization, asset management, workforce development, consulting and operational improvement.
- **Services and education** — Maintenance, repairs, spare parts, upgrades, equipment performance management, financing, clinical education, e-learning, planning and design.

## Achievements

- The Siemens medical-technology lineage produced an industrially manufactured medical X-ray device in 1896, one year after the discovery of X-rays.
- Siemens Healthineers listed on the Frankfurt Stock Exchange on March 16, 2018 and entered Germany's DAX index in September 2021.
- Completed the combination with Varian Medical Systems in April 2021, adding a broad radiation-oncology and cancer-care portfolio.
- Reported €23.375 billion in fiscal 2025 revenue, up 5.9% on a comparable basis.
- Reported more than 25,000 technical intellectual-property rights, including over 16,000 granted patents, at fiscal year-end 2025.
- Spent €1.958 billion on R&D in fiscal 2025, equal to 8% of revenue.
- Recorded about 3.006 billion patient touchpoints worldwide in fiscal 2025.
- Built more than 200 Value Partnerships by the end of fiscal 2025.

## Latest updates

- **2026-07** — Third-quarter comparable revenue grew 2.8%; Imaging grew 2.3%, Precision Therapy 9.2% and Diagnostics declined 5.5%. The company lowered its fiscal 2026 comparable growth outlook to 3.5%-4.0% and raised adjusted EPS guidance to €2.35-€2.45 after tariff refunds.
- **2026-07** — Vanderbilt Health and Siemens Healthineers announced an $87 million Value Partnership for imaging, radiation oncology, workforce development and scalable AI workflows.
- **2026-07** — The company launched capillary testing claims for 24 assays on Atellica analyzers and introduced the Atellica HEMA 580 hematology analyzer.
- **2026-06** — Siemens Healthineers received a $6.9 million ARPA-H research project contract to develop AI-based cyber-resilience approaches for healthcare devices.
- **2026-04** — ARPA-H awarded the company up to $83 million, including a $23 million company cost share, for a five-year effort to advance photon Flash radiotherapy.
- **2026-02** — Mayo Clinic and Siemens Healthineers expanded work across neurodegenerative disease, prostate cancer, liver metastases, digital twins and advanced imaging.

## Links

- Website: https://www.siemens-healthineers.com
- LinkedIn: https://www.linkedin.com/company/siemens-healthineers
- Twitter/X: https://x.com/SiemensHealth
- GitHub: https://github.com/siemens-healthineers
- YouTube: https://www.youtube.com/siemenshealthineers
- Instagram: https://www.instagram.com/siemens.healthineers/
- Facebook: https://www.facebook.com/SiemensHealthineers

---

Profile page: https://yespress.io/siemens-healthineers
Published by YesPress — https://yespress.io
Last updated: 2026-08-11